Next Article in Journal / Special Issue
Improving Screening Programmes for Sickle Cell Disorders and Other Haemoglobinopathies in Europe: The Role of Patient Organisations
Previous Article in Journal / Special Issue
A Multicentre Pilot Study of a Two-Tier Newborn Sickle Cell Disease Screening Procedure with a First Tier Based on a Fully Automated MALDI-TOF MS Platform
Open AccessReview

The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD)

1
Policy of Integral Attention to People with Sickle Cell Disease (PIAPSCD), Technical Advisory Council for Sickle Cell Disease (TAC-SCD), CGSH/DAET/SAS, Ministry of Health, Asa Norte Brasília 70719-040, Brazil
2
Regional Blood Center of Ribeirão Preto, HC-FMRP, University of Sao Paulo (USP), Campus Universitário, Ribeirão Preto 14049-900, Brazil
3
National Newborn Screening Program Policy (NNSPP)/CGSH/SAS, Ministry of Health, Asa Norte Brasília 70719-040, Brazil
4
State Health Secretariat, State of Pernambuco, Recife 50751-530, Brazil
5
Newborn Screening Program, APAE-Salvador, Salvador 41830-141, Brazil
*
Author to whom correspondence should be addressed.
Int. J. Neonatal Screen. 2019, 5(1), 11; https://doi.org/10.3390/ijns5010011
Received: 28 September 2018 / Revised: 21 January 2019 / Accepted: 23 January 2019 / Published: 26 January 2019
Since 2001, the Brazilian Ministry of Health has been coordinating a National Neonatal Screening Program (NNSP) that now covers all the 26 states and the Federal District of the Brazilian Republic and targets six diseases including sickle cell disease (SCD) and other hemoglobinopathies. In 2005, the program coverage reached 80% of the total live births. Since then, it has oscillated between 80% and 84% globally with disparities from one state to another (>95% in São Paulo State). The Ministry of Health has also published several Guidelines for clinical follow-up and treatment for the diseases comprised by the neonatal screening program. The main challenge was, and still is, to organize the public health network (SUS), from diagnosis and basic care to reference centers in order to provide comprehensive care for patients diagnosed by neonatal screening, especially for SCD patients. Considerable gains have already been achieved, including the implementation of a network within SUS and the addition of scientific and technological progress to treatment protocols. The goals for the care of SCD patients are the intensification of information provided to health care professionals and patients, measures to prevent complications, and care and health promotion, considering these patients in a global and integrated way, to reduce mortality and enhance their quality of life. View Full-Text
Keywords: neonatal screening; sickle cell disease; hemoglobinopathies neonatal screening; sickle cell disease; hemoglobinopathies
Show Figures

Figure 1

MDPI and ACS Style

Silva-Pinto, A.C.; Alencar de Queiroz, M.C.; Antoniazzo Zamaro, P.J.; Arruda, M.; Pimentel dos Santos, H. The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD). Int. J. Neonatal Screen. 2019, 5, 11.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop